Genetic Inhibition of Mitochondrial Permeability Transition Pore Exacerbates Ryanodine Receptor 2 Dysfunction in Arrhythmic Disease
Cells · 2023
DOI: 10.3390/cells12020204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Arpita Deb und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Mississippi State University, Starkville, MS 39762, USA. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Tachycardia, Ventricular. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH.
Abstract (Originalsprache)
The brief opening mode of the mitochondrial permeability transition pore (mPTP) serves as a calcium (Ca2+) release valve to prevent mitochondrial Ca2+ (mCa2+) overload. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a stress-induced arrhythmic syndrome due to mutations in the Ca2+ release channel complex of ryanodine receptor 2 (RyR2). We hypothesize that inhibiting the mPTP opening in CPVT exacerbates the disease phenotype. By crossbreeding a CPVT model of CASQ2 knockout (KO) with a mouse missing CypD, an activator of mPTP, a double KO model (DKO) was generated. Echocardiography, cardiac histology, and live-cell imaging were employed to assess the severity of cardiac pathology. Western blot and RNAseq were performed to evaluate the contribution of various signaling pathways. Although exacerbated arrhythmias were reported, the DKO model did not exhibit pathological remodeling. Myocyte Ca2+ handling was similar to that of the CASQ2 KO mouse at a low pacing frequency. However, increased ROS production, activation of the CaMKII pathway, and hyperphosphorylation of RyR2 were detected in DKO. Transcriptome analysis identified altered gene expression profiles associated with electrical instability in DKO. Our study provides evidence that genetic inhibition of mPTP exacerbates RyR2 dysfunction in CPVT by increasing activation of the CaMKII pathway and subsequent hyperphosphorylation of RyR2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Mississippi State University, Starkville, MS 39762, USA.
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Bioinformatics Center, Beijing University of Agriculture, Beijing 102206, China.
- School of Pharmacy, Division of BioMolecular Sciences, University of Mississippi, Oxford, MS 38677, USA.
- Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
ORCID-Profile: James A Stewart, Ying Wang
Förderung
- NHLBI NIH HHS
- NIH
Zitieren
APA
Deb, A., Tow, B. D., Qing, Y., Walker, M., Hodges, E. R., Stewart, J. A., Knollmann, B. C., Zheng, Y., Wang, Y., & Liu, B. (2023). Genetic Inhibition of Mitochondrial Permeability Transition Pore Exacerbates Ryanodine Receptor 2 Dysfunction in Arrhythmic Disease. Cells. https://doi.org/10.3390/cells12020204
Vancouver
Deb A, Tow BD, Qing Y, Walker M, Hodges ER, Stewart JA, et al. Genetic Inhibition of Mitochondrial Permeability Transition Pore Exacerbates Ryanodine Receptor 2 Dysfunction in Arrhythmic Disease. Cells. 2023. doi:10.3390/cells12020204
BibTeX
@article{Deb2023,
author = {Deb, Arpita and Tow, Brian D and Qing, You and Walker, Madelyn and Hodges, Emmanuel R and Stewart, James A and Knollmann, Björn C and Zheng, Yi and Wang, Ying and Liu, Bin},
title = {Genetic Inhibition of Mitochondrial Permeability Transition Pore Exacerbates Ryanodine Receptor 2 Dysfunction in Arrhythmic Disease},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12020204}
}
EUVIMED